Merck And Regenstrief Institute Establish Evidence-Based Care Collaboration
The Regenstrief Institute and Merck, known as MSD outside the United
States and Canada, have signed a five-year agreement to collaborate on a
range of projects that will use clinical data to inform personalized
The Regenstrief Institute and Merck, known as MSD outside the United States and Canada, have signed a five-year agreement to collaborate on a range of projects that will use clinical data to inform personalized delivery of health care. The work will explore novel methods for studying diseases and interventions for chronic conditions such as diabetes, cardiovascular disease and osteoporosis. Ultimately, the Regenstrief-Merck collaboration seeks to improve the health of patients through data analytics, health care innovation, education and research that supports evidence-based health care. Financial details were not disclosed. “Regenstrief has a passion for determining how personalization of medicine can be achieved by better understanding and using health data,” said Regenstrief investigator and innovations officer Jon Duke, M.D., who serves as the institute’s lead investigator for the partnership. “Regenstrief brings rigorous science to clinical environments and has more than 40 years of experience as an international leader in improving health care delivery through informatics and health services research. With Merck’s depth of expertise and its global reach, we hope to develop and test new approaches to care, and advance successful models of health care broadly.” Dr. Duke also is an assistant professor of medicine at the Indiana University School of Medicine. Both Regenstrief, a medical research organization closely associated with the Indiana University School of Medicine, and Merck, a global health care leader, are committed to generating new knowledge to improve health. "This type of novel academic-industry collaboration can advance our understanding of a number of critical therapeutic areas, enabling novel use of health information technology to enhance drug development, medication safety and the personalization of therapeutics," said Sachin H. Jain, M.D., chief medical information and innovation officer at Merck. Regenstrief Institute An internationally respected informatics and health care research organization, the Regenstrief Institute is recognized for its role in improving quality of care, increasing efficiency of health care delivery, preventing medical errors and enhancing patient safety. Established in 1969, the institute is closely associated with the Indiana University School of Medicine and the Health and Hospital Corporation of Marion County.